- Anti-angiogenic gene therapy for brain tumors
Principal Investigator: Lynn Hlatky, PhD
Institute: Dana-Farber Cancer Institute
Initiative: Unrestricted Grant
Location: Boston, MA
- Anti-angiogenic treatment for enhancement of anti-tumor effects of oncolytic viruses
Principal Investigator: Balveen Kaur, PhD
Institute: Ohio State University
Initiative: Glioblastoma Multiforme Grant
Location: Columbus, OH
- Anti-HGF Monoclonal Antibody Therapy for Malignant Glioma
Principal Investigator: John Laterra, MD, PhD
Institute: Kennedy Krieger Inst.
Initiative: Unrestricted Grant
Location: Baltimore, MD
- Antiangiogenetic immunotherapy of malignant brain tumors
Principal Investigator: John H. Sampson, MD, PhD
Institute: Duke University Medical Center
Initiative: Unrestricted Grant
Location: Durham, NC
- Antihistamines and Adult Gliomas
Principal Investigator: Michael Scheurer, PhD, MPH
Institute: MD Anderson Cancer Center
Initiative: The Jean Logsdon Epidemiology Grant
Location: Houston, TX
- Applications of lipid-coated midrobubble ultrasonic contrast to the therapy of brain tumors
Principal Investigator: Richard Simon, MD
Institute: University of Connecticut
Initiative: Unrestricted Grant
Location: Farmington, CT
- Are neural stem cells a source of brain tumors?
Principal Investigator: Arturo Alvarez-Buylla, PhD
Institute: University of California, San Francisco
Initiative: Unrestricted Grant
Location: San Francisco, CA
- Ataxia Telangiectasia (ATM) haplotypes and risk of sporadic and radiation associated meningiomas
Principal Investigator: Siegal Sadetzki, MD, MPH
Institute: The Gertner Institute for Epidemiology and Health Policy Research
Initiative: The Brain Tumor Epidemiology Research Grant
Location: Tel Aviv, Israel
- Blockade of glioblastoma tumor progression by specific mRNA translation inhibition
Principal Investigator: David Wells, PhD
Institute: Yale University
Initiative: Glioblastoma Multiforme Grant
Location: New Haven, CT
- Blocking autophagy and increasing ER stress to improve therapy of GBM
Principal Investigator: Axel H. Schonthal, PhD
Institute: University of California Keck School of Medicine
Initiative: Standard Research Grant
Location: Los Angeles, CA